Hepatitis B Clinical Trials

Garden Grove : Sc Clinical Research, Inc.

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Los Angeles :

Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients

Palo Alto : Stanford University

Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy While on the Orthotopic Liver Transplant (OLT) List

Sacramento : University Of California Davis Medical Center

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

San Diego : University of California Antiviral Research Center (AVRC)

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

View More »

San Diego : University of California Antiviral Research Center (AVRC)

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

San Francisco :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

New Haven : Yale University School Of Medicine

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Washington : Georgetown University Hospital

Evaluating Blood Glucose Levels During Infusion With HepaGam B (HBIG) in Post-liver Transplant Patients

Stockbridge : Clinical Research Atlanta

Hepatitis B vaccine for adults with type II diabetes.

View More »

Atlanta : Atlanta Gastroenterology Associates

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Atlanta :

Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients

Indianapolis : Indiana University Medical Center

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Indianapolis : Indiana University Medical Center

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

New Orleans : Tulane University Health Sciences Center

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

New Orleans : Tulane University Health Sciences Center

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Baltimore :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Baltimore : Mercy Medical Center

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Bethesda : National Institute of Allergy and Infectious Diseases

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Bethesda : National Institute of Allergy and Infectious Diseases

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Columbia : Gastro Center Of Maryland

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Boston : Beth Israel Deaconess Medical Center

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Boston :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Boston : BIDMC

FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy

Boston : Massachusetts General Hospital

Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy While on the Orthotopic Liver Transplant (OLT) List

Detroit : Henry Ford Health System

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Detroit : Henry Ford Health System

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Minneapolis :

Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients

Kansas City : Kansas City Gastroenterology and Hepatology

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Kansas City : Kansas City Gastroenterology and Hepatology

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

St. Louis :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

St. Louis : Bruce Bacon M.D.

FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy

New York : Clinilabs, Inc.

Do you have Hepatitis B?

View More »

Flushing : Office Of Sing Chan Md

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Flushing : Medical Procare, Pllc

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

New York : Weill Cornell Medical College

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

New York : CliniLabs

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

New York : Weill Cornell Medical College

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

New York : CliniLabs

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

New York : New York School of Medicine

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

New York :

Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients

Durham : Duke University Medical Center

FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy

Wilmington : Registry Coordinating Center

Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women.

Cleveland : University Hospitals Case Medical Center

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Cleveland : University Hospitals Case Medical Center

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Portland : Oregon Health Science University

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Philadelphia : CRI Worldwide, LLC

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Houston : Baylor College of Medicine

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Houston : Baylor College of Medicine

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Houston : Texas Children's Hospital

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

Salt Lake City : J. Lewis Research, Inc.

Research study of a Hepatitis B vaccine in adults 20 to 49 years of age, with or without Type 2 Diabetes

View More »

Salt Lake City : University of Utah

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Salt Lake City : University of Utah

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Seattle :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Clayton : Monash University, Department of Medicine

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Clayton : Monash University, Dept. of Medicine

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Herston : Royal Brisbane and Women's Hospital

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Herston : Royal Brisbane and Women's Hospital

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Melbourne : Alfred Hospital, Department of Gastroenterology

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

View More »

Melbourne :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Melbourne : The Alfred Hospital

A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infected Patients

Melbourne : The Alfred Hospital

HIV-HBV Co-Infection and Liver Disease

Nedlands : Royal Perth Hospital

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Nedlands : Royal Perth Hospital

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

North Adelaide :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

North Ryde : Merck Sharp & Dohme

A Study of the Safety and Efficacy of PEG-Intron™ Versus PEGASYS™ in Participants With Chronic Hepatitis B (P08450 AM1)

Sydney :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Antwerpen : GSK Investigational Site

Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface Antigen (HBsAg) in Combination With a GlaxoSmithKline (GSK) Biologicals' Adjuvant System

Brussels :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Gent :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Pleven : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B

Plodiv : University Multiprofile Hospital for Active Treatment "Sveti Georgi"

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

Plovdiv : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B

Sofia :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Sofia : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B

View More »

Sofia : Multiprofile Hospital for Active Treatment "Tokuda Hospital"

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

Sofia : Novartis Investigative Site

Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept

Stara Zagora : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B

Varna :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Varna : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B

Varna : Novartis Investigative Site

Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept

Calgary : University of Calgary, Heritage Medical Research Center

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Calgary : University of Calgary, Heritage Medical Research Center

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Edmonton : University of Alberta Hospital

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Edmonton : University of Alberta Hospital

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Laval : Algorithme Pharma, Inc.

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

View More »

Montreal : Algorithme Pharma, Inc.

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Montreal :

Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients

Beijing : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Beijing : Local Institution

Effectiveness of Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB Patients in China

Beijing : Beijing Youan Hospital, Capital Medical University

Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B

Beijing : National Center for AIDS/STD Control and Prevention, China CDC

Efficacy and Safety of TDF+3TC+EFV in Adults With HIV/HBV Coinfection

Beijing : People's Hospital Under Beijnig University

EFFORT Extension Study

View More »

Beijing : Department of Infectious Disease, First Hospital of Peking University

EFFORT Extension Study

Beijing : 302 Military Hospital Of China

EFFORT Extension Study

Beijing : BeiJing YouAn Hospital ,Capital Medical University

EFFORT Extension Study

Beijing : Beijing Friendship Hospital Attached To The Capital Medical University

EFFORT Extension Study

Beijing : Beijing Ditan Hospita

EFFORT Extension Study

Chang Chun : Hepatobiliary Disease Hospital of Jilin Province

Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus

Changchun : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Changchun : First Hospital .Jilin Unniversity

EFFORT Extension Study

Changsha : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Changsha : Xiangya Hospital Central-South Univrsity

EFFORT Extension Study

Changshu : Local Institution

Effectiveness of Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB Patients in China

Changzhou : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Chengdu : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Chengdu : West China Hospital.SiChuan University

EFFORT Extension Study

Chongqing : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Chongqing : Southwest Hospital

Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B

Chongqing : Second Affiliated Hospital Chongqing Medical University

Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B

Chongqing : The Second Affiliated of ChongQing University of Medical Science

EFFORT Extension Study

Chongqing : Southwest Hospital

Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus

Dalian : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Daqing : Local Institution

Effectiveness of Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB Patients in China

Foshan : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Foushan : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Fuzhou : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Fuzhou : Fuzhou Infectious Disease Hospital

Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B

Guangzhou : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Guangzhou : Guangzhou Eighth People's Hospital

Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B

Guangzhou : No. 8 People's Hospital In GuangZhou

EFFORT Extension Study

Guangzhou : Department of Infectious Disease, Nanfang Hospital

EFFORT Extension Study

Guangzhou : The Third Hospital of Sun Yat-Sen University

EFFORT Extension Study

Haikou : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Hangzhou : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Hangzhou : The First Affiliated Hospital of College of Medicine, Zhejiang University

EFFORT Extension Study

Hangzhou : The Sixth People's Hospital of Hangzhou

EFFORT Extension Study

Harbin : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Hefei : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Hong Kong : Department of Medicine, Queen Mary Hospital

Effects of Telbivudine and Tenofovir Disoproxil Fumarate Treatment on the Hepatitis B Virus DNA Kinetics in CHB

Jiangmen : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Jiangyin : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Jinan : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Jinan : Jinan Infectious Disease Hospital

Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B

Jinan : JiNan Infectious Diseases Hospital

EFFORT Extension Study

Kunming : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Lanzhou : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Lanzhou : First Affiliated Hospital of Lanzhou University

Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B

Liuzhou : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Nan Jing : The Second Affiliated Hospital of the Southeast University

Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus

Nanchang : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Nanjing : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Nanjing : No.81 Hospital of PLA

EFFORT Extension Study

Nanning : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Nanyang : Nanyang Central Hospital

Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus

Ningbo : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Ordos : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Qingdao : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Shanghai : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Shanghai : Changhai Hospital affiliated to Second Military Medical University

EFFORT Extension Study

Shanghai : No.85 Hospital of PLA

EFFORT Extension Study

Shanghai : Shanghai Ruijin Hospital

EFFORT Extension Study

Shanghai : Huashan Hospital，Fudan University

EFFORT Extension Study

Shen Yang : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Shengyang : ShengJing Hospital of China Medical University

EFFORT Extension Study

Shenyang : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Shenyang : Shenyang Sixed People's Hospital

Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B

Shenzhen : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Shi Jiazhuang : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Shijiazhuang : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Shijiazhuang : The Fifth Hospital of Shijiazhuang

Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus

Suining : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Suzhou : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Taiyuan : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Taiyuan : First Affiliated Hospital, Shanxi University

Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B

Taizhou : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Tianjin : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Tianjin : Tianjin Third Central Hospital

Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B

Urumqi : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Wenzhou : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Wuhan : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Wuhan : Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology

EFFORT Extension Study

Wuxi : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Xiamen : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Xian : Tangdu Hospital

EFFORT Extension Study

Xi'an : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Xi'an : Xijing Hospital

Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B

Xi'an : Tangdu Hospital, Fourth Military Medical University

Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B

Yancheng : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Yangzhou : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Yichang : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Zhaoqing : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Zhengzhou : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Zhengzhou : Henan Provincial People's Hospital

Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B

Zhenjiang : Updated

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Lyon : Hopital de la Croix Rousse

A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant

Paris : Consultation d'Accueil, de Soins et d'Orientation (CASO) de Médecins du Monde (MDM)

Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests

Paris : Hopital Cochin CIC de vaccinologie

Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected Patients

Villejuif : Hôpital Paul Brousse

A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant

Berlin : Private Practice

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Berlin : Charite CVK

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Berlin : Leberzentrum am Checkpoint

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Bonn : Universitaetsklinikum Bonn

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Duesseldorf : Zentrum für HIV und Hepatitis

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

View More »

Essen : Novartis Investigative Site

Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept

Frankfurt : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Frankfurt : J.W. Goethe Universitaetsklinikum

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Freiburg : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Hamburg : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Hamburg : Universitaetsklinikum Hamburg Eppendorf

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Hamburg : ifi Studien und Projekte GmbH

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Hamburg : Novartis Investigative Site

Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept

Hannover : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Hannover : Medizinische Hochschule Hannover

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Heidelberg : Universitaetsklinik Heidelberg

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Herne : Gastroenterologische Gemeinschaftspraxis

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Herne : Novartis Investigative Site

Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept

Leipzig : Universitaetsklinikum Leipzig

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Leipzig : Novartis Investigative Site

Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept

Leverkusen : Gemeinschaftspraxis Gastroenterologie

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Mainz : Universitätsmedizin Mainz, I. Med. Klinik und Poliklinik

Peg-interferon ADDed to an Ongoing Nucleos(t)Ide Based Treatment in Patients With Chronic Hepatitis B to Induce Decrease of HBs-Antigen

Muenchen : Klinikum der LMU Grosshadern

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Muenster : Centrum interdisziplinaere Medizin

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Tuebingen : Universitaetsklinik Tuebingen

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Ulm : Universitaetsklinikum Ulm

Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB

Kowloon : Princess Margaret Hospital

A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection

New Territories : Tuen Mun Hospital

A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection

Pokfulam : Queen Mary Hospital

A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection

Shatin : Prince of Wales Hospital

A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection

Tai Po : Alice Ho Miu Ling Nethersole Hospital

A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection

Chandigarh : School of Public Health, Post Graduate Institute of Medical Education and Research

Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine

Haifa :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Jerusalem :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Zefat :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Bari :

A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253

Bologna : S. Orsola Hospital

A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant

Cagliari : Ospedale Brotzu

A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant

Cagliari :

A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253

Castellana Grotte :

A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253

View More »

Firenze : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Milano :

A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253

Modena : Liver and Multivisceral Transplant Center, University of Modena and Reggio Emilia

A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant

Modena : A.O.U. Policlinico Università di Modena e Reggio Emilia

Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients

Napoli :

A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253

Padova : Azienda Ospedialera di Padova

A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant

Padova :

A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253

Padova : Az. Ospedaliera Universitaria di Padova

Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients

Palermo :

A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253

Pisa : Azienda Ospedaliero Universitaria Pisana

Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients

Roma : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Torino : Molinette Hospital

A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant

Torino :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Torino : Az. Ospedaliera S.Giovanni Battista di Torino

Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients

Bucheon : Soon Chun Hyang University Bucheon Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Busan : Inje University Haeundae Paik Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Busan : Kosin University Gospel Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Busan : Dong-A University Medical Center

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Cheonan : Dankook University Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

View More »

Chuncheon : Chuncheon Sacred Heart Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Daegu : Yeungnam University Medical Center

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Daegu : Kyungpook National University Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Daegu : Kyungpook National University

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

Guri : Hanyang University Guri Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Incheon : Gachon University Gil Hospital, Department of Pediatrics

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

Jeju : Jeju National University Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Seongnam : SKChemicals

A Confirmatory Study of Hepabulin IV in HBsAg Positive Liver Transplantation Recipients

Seoul : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Seoul : Kyunghee university Medical Center

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Seoul : Hanyang University Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Seoul : Inje University Sanggye Paik Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Seoul : Konkuk University Medical Center

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Seoul : Kangbuk Samsung Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Seoul : Kangdong Sacred Heart Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Seoul : Kangnam Severance Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Seoul : Severance Children's Hospital

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

Seoul : Shinchon Severance Hospital

HBsAg Related Response Guided Therapy

Seoul : Department of clinical pharmacology and therapeutics

Safety and Pharmacokinetics Study of Healthy Male Adults When Repeatedly Administered Through Intravenous Injection

Seoul : The Catholic University of Korea Seoul St. Mary's Hospital

Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy With HB110E

Sungnam : Bundang CHA medical center

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Uijeongbu : Uijeongbu St.Mary's Hospital

A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis B Who Have HBeAg(+)

Uijeongbu : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Wonju : Wonju Christian Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Yangsan : Busan National University Yangsan Hospital

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Yangsan-si : Pusan National University Yangsan Hospital

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

Rotterdam : Erasmus Medical Center

PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B Patients

Grafton : Auckland Clinical Studies

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

Grafton : Aukland Clinical Studies

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Bydgoszcz :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Bydgoszcz : Collegium Medicum Uniwersytet im. Mikołaja Kopernika

A Study to Assess DV-601 in Subjects With Chronic Hepatitis B

Bytom :

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) Analogues

Gdansk :

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) Analogues

Krakow :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

View More »

Krakow :

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) Analogues

Lancut :

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) Analogues

Myslowice :

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) Analogues

Poznan :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Raciborz :

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) Analogues

Szczecin : Samodzielny Publiczny Wojewódzki Szpital Zespolony

A Study to Assess DV-601 in Subjects With Chronic Hepatitis B

Warsaw : Wojewódzki Szpital Zakaźny

A Study to Assess DV-601 in Subjects With Chronic Hepatitis B

Wroclaw :

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) Analogues

Wrocław : NZOZ Centrum Badan Klinicznych

A Study to Assess DV-601 in Subjects With Chronic Hepatitis B

Bucharest : National Institute of Infectious Diseases

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

Bucharest : Fundeni Clinical Institute - Constantinesco

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

Bucharest : Grigore Alexandrescu Emergency Clinical Hospital for Children

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

Constanta : Clinical Infectious Diseases Hospital of Constanta

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

Craiova : "Victor Babes" Clinical Hospital of Infectious Diseases and Pneumophtisology

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

Moscow :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Samara :

A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B

St Petersburg :

A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B

Stavropol :

A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B

Barcelona : Hospital Clinic de Barcelona

A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant

Barcelona : Novartis Investigative Site

Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept

El Palmar : Novartis Investigative Site

Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept

Changhua : Changhua Christian Hospital

Comparison Between Lamivudine and Entecavir Treatment in Patients

ChiaYi : Chia-Yi Christian

Comparison Between Lamivudine and Entecavir Treatment in Patients

Chia-Yi : Chia-Yi Christine Hospital

Tenofovir in Chronic Hepatitis B With Mild ALT Elevation

Kaohsiung : E-Da Hospital

Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma

Kaohsiung : E-Da Hospital

Tenofovir in Chronic Hepatitis B With Mild ALT Elevation

View More »

Taichung : Taichung Veterans General Hospital

Comparison Between Lamivudine and Entecavir Treatment in Patients

Taichung : Taichung Veterans General Hospital

Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma

Taichung : Taichung Veterans General Hospital

Tenofovir in Chronic Hepatitis B With Mild ALT Elevation

Taipei : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Taipei : Taipei Veterans General Hospital

Evaluating the Efficacy, Safety and Tolerability of Tenofovir DF in Pediatric Patients With Chronic Hepatitis B Infection

Taipei : National Taiwan University Hospital Department of Internal medicine

Pegasys Plus Entecavir Versus Entecavir Alone for Hepatitis Be Antigen-Positive Chronic Hepatitis B

Taipei : Department of Internal Medicine

Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C

Taoyuan : Local Institution

Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen

Yunlin County : National Taiwan University Hospital Yun-Lin Branch

Tenofovir in Chronic Hepatitis B With Mild ALT Elevation

Bangkok :

A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B

Bangkok : Bhumibol Adulyadej Hospital

Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand

Chantaburi : Prapokklao Hospital

Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand

Chiang Mai :

A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B

Chiang Rai : Chiangrai Prachanukroh Hospital

Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand

View More »

Chonburi : Chonburi Regional Hospital

Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand

Khon Kaen :

A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B

Phayao : Phayao Provincial Hospital

Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand

Songkhla :

A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B

Kyiv :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Birmingham : University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital

A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant

Birmingham :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

London : King's College Hospital

A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant

London :

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B